Cubist Systematic Strategies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,300
Closed -$406K 3081
2024
Q4
$406K Hold
13,300
﹤0.01% 2266
2024
Q3
$305K Buy
13,300
+4,000
+43% +$113K ﹤0.01% 2417
2024
Q2
$269K Buy
+9,300
New +$217K ﹤0.01% 2400

Other funds holding GH

Cubist Systematic Strategies's GH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Guardant Health (GH) in Q3 2025, closing a stake of 329,322 shares — an estimated $17.9M sold.

Cubist Systematic Strategies first reported a position in GH in Q1 2019 and held it in 21 quarters. The position peaked at $17.1M in Q2 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 329,322 Guardant Health shares in Q3 2025, an estimated $17.9M.
  • Cubist Systematic Strategies first reported a position in Guardant Health in Q1 2019 and held it in 21 quarters.
  • Cubist Systematic Strategies's Guardant Health position peaked at $17.1M in Q2 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.